<DOC>
	<DOC>NCT00735683</DOC>
	<brief_summary>This primary purpose of this study is to determine if ATHX-105 phosphate causes weight loss over a 12-week period.</brief_summary>
	<brief_title>A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety</brief_title>
	<detailed_description>The rate of obesity in adults continues to increase. Obesity affects overall health and is associated with an increased risk for diabetes, high blood pressure, coronary artery disease, osteoarthritis, and sleep apnea. To date, the medication options to treat obesity have been limited. This study will examine if a new investigational drug, ATHX-105 phosphate, may cause weight loss in humans over a 12-week period.</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Obese adults with a body mass index of 3045 kg/m2 Pregnancy Diabetes Adults with serious or unstable current or past medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Weight loss</keyword>
	<keyword>Weight-loss drugs</keyword>
	<keyword>Obesity</keyword>
	<keyword>Overweight</keyword>
	<keyword>Body weight</keyword>
	<keyword>Diet</keyword>
	<keyword>Metabolic Disorder</keyword>
	<keyword>Nutrition Disorder</keyword>
</DOC>